NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its second quarter revenues increased 3 percent year over year, due in part to its January acquisition of AbD Serotec.

The Hercules, Calif.-based firm brought in total revenues of $525.3 million for the three months ended June 30, compared to $$510.4 million for the second quarter of 2012. It fell short of the consensus Wall Street estimate of $532.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.